1 terminated, 1 withdrawn. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow CD20-Positive Neoplastic Cells Present: new trials by email Literature Review of CD20-Positive Neoplastic Cells Present trials Research Report on CD20-Positive Neoplastic Cells Present
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Ibrutinib Plus Rituximab and Lenalidomide in Treating Elderly Participants With Newly Diagnosed Mantle Cell Lymphoma Dexamethasone, Ibrutinib, Lenalidomide - CCND1 Positive, CD20-Positive Neoplastic Cells Present | Phase 2 | Withdrawn | M.D. Anderson Cancer Center | 2019-07-01 | 2019-08-22 | |
| Anti-CD20 Radioimmunotherapy Before Chemotherapy and Stem Cell Transplant in Treating Patients With High-Risk B-Cell Malignancies Anti-CD20 B9E9 scFv-Streptavidin Fusion Protein, Autologous Hematopoietic Stem Cell Transplantation, Carmustine - Burkitt Lymphoma, CD20-Positive Neoplastic Cells Present | Phase 1 | Terminated | Fred Hutchinson Cancer Center | 3 | 2017-02-01 | 2020-11-23 |
Lymphoma, Mantle-Cell (2) · Burkitt Lymphoma (1) · Lymphoma, B-Cell (1) · Lymphoma, Large B-Cell, Diffuse (1)
Hemic and Lymphatic Diseases (2) · Immune System Diseases (2) · Immunoproliferative Disorders (2) · Lymphatic Diseases (2) · Lymphoma (2) · Lymphoma, Non-Hodgkin (2) · Lymphoproliferative Disorders (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · DNA Virus Infections (1) · Epstein-Barr Virus Infections (1) · Herpesviridae Infections (1) · Infections (1) · Tumor Virus Infections (1) · Virus Diseases (1)
CT-P10 (1) · Calcium Dobesilate (1) · Carmustine (1) · Cytarabine (1) · DOTA-biotin (1) · Dexamethasone (1) · Etoposide (1) · Indium (1) · Lenalidomide (1) · Melphalan (1) · Peripheral Blood Stem Cell Transplantation (1) · Rituximab (1) · auricularum (1) · carmustine, poliferprosan 20 drug combination (1) · dexamethasone 21-phosphate (1)
Fred Hutchinson Cancer Center (1) · M.D. Anderson Cancer Center (1)
United States (1)
Ajay Gopal (1)
P01CA044991 (1), P30CA015704 (1), P30CA016672 (1)